PDE3A and lung adenocarcinoma: Nazir et al. showed high levels of PDE3A expression in different cancer cell lines such as colon carcinoma or lung adenocarcinoma and underlined higher sensitivity to PDE3 inhibitors leading to reduced cell viability compared to other cells lines expressing less PDE3A [17].